• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 145276-12
Device Problems Material Separation (1562); Detachment of Device or Device Component (2907); Material Split, Cut or Torn (4008)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Code Available (3191)
Event Date 09/27/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.As the stent was deployed successfully, the delivery system has been returned and will be evaluated.As soon as further information regarding this event becomes available a follow-up supplemental form will be provided within 30 days of awareness of this information.
 
Event Description
On the (b)(6) 2019 a patient was being implanted with a biomimics 3d vascular stent system.The stent deployed successfully however during pullback the outer sheath remained on the handle and the inner sheath remained in the vessel.The implanting physician was able to remove the inner sheath and the patient was unharmed.There was a clinically significant extension in the procedure time.
 
Manufacturer Narrative
As part of the investigation into this adverse event veryan conducted : 1) analysis of the returned delivery system which included visual assessment,measurements, in process lot release test data review 2) angiography review 3) follow-up communication with reporting physician, dr (b)(6) at (b)(6).The conclusions of the investigation were : 1) that the stent deployed as expected without any issues, 2) the inner peek liner to the inner shaft bond on the delivery system has a design specification of 5n which has been confirmed as appropriate through design verification and validation testing.In-process control testing for this lot confirmed that the units tested exceeded the 5n specification.3) there was elongation of the inner peek liner which occurred during the procedure, which indicates that a tensile event of greater than 5n occurred, to separate the peek liner from the inner shaft.It is possible that such a tensile event and associated elongation of the inner peek liner could have occurred when retracting the delivery system post deployment of the stent.4) the reporting physician reported minimal resistance felt during delivery system pullback following stent placement.The source of the resistance which resulted in the inner peek liner detachment from the rest of the delivery system is unknown.It is possible that the tip of the delivery system may have snagged on the stent during retraction from the vessel post deployment.This could have contributed to the resistance experienced by the physician during retraction.It is also possible that the guide-wire used during deployment of the stent may have lost its lubricity.The terumo guide-wire used has a hydrophilic coating and can loose lubricity and become sticky, creating friction with the inner peek liner, which could also be a reason for the resistance felt by the physician and detachment of the inner peek liner from the delivery system.5) the physician stated he was not concerned about this case although it was a little tricky there was no harm to the patient.Following the investigation the complaint was categorised as "detachment of peek inner liner" and the root cause is defined as unknown.It could not be established if the complaint is related to a deficiency of the device.All manufacturing history for this device show that it was manufactured as intended with no issues relevant to this complaint.In addition there have been no other complaints of this nature from sales of over 8000 biomimics 3d vascular stent systems sold to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL
unit 11 galway technology park
parkmore
galway city, H91 V E0H
EI  H91 VE0H
MDR Report Key9320375
MDR Text Key216348777
Report Number3011632150-2019-00111
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/14/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2021
Device Catalogue Number145276-12
Device Lot Number0000007240
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/24/2019
Date Manufacturer Received10/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-